Publications

Included here is a list of publications from OCG programs. All published data are available to the research community through the program-specific data matrices.

* denotes publications from the CTD2 initiative that are results of intra-Network collaborations

 

CTD²
January 08, 2021

A modular master regulator landscape controls cancer transcriptional identity

Cell
Read more >
CTD²
December 15, 2020

Synthetic Lethal Interaction between the ESCRT Paralog Enzymes VPS4A and VPS4B in Cancers Harboring Loss of Chromosome 18q or 16q

Cell Reports
Read more >
CTD²
December 11, 2020

A meta-learning approach for genomic survival analysis

Nature Communications
Read more >
CTD²
December 04, 2020

Hypomorph Mutation-Directed Small-Molecule Protein-Protein Interaction Inducers to Restore Mutant SMAD4-Suppressed TGF-β Signaling

Cell Chemical Biology
Read more >
CTD²
November 30, 2020

N-quinoline-benzenesulfonamide derivatives exert potent anti-lymphoma effect by targeting NF-κB

iScience
Read more >
CTD²
October 26, 2020

Large-Scale Characterization of Drug Responses of Clinically Relevant Proteins in Cancer Cell Lines

Cancer Cell
Read more >
CTD²
October 12, 2020

Functional precision medicine identifies new therapeutic candidates for medulloblastoma

Cancer Research
Read more >
CTD²
October 05, 2020

Inhibition of the ATM/Chk2 axis promotes cGAS/STING signaling in ARID1A-deficient tumors

The Journal of Clinical Investigation
Read more >
CTD²
October 01, 2020

BET, SRC, and BCL2 family inhibitors are synergistic drug combinations with PARP inhibitors in ovarian cancer

EBioMedicine
Read more >
CTD²
September 28, 2020

Development of a DNA Methylation-Based Diagnostic Signature to Distinguish Benign Oncocytoma From Renal Cell Carcinoma

JCO Precision Oncology
Read more >

Pages

* denotes publications from the CTD2 initiative that are results of intra-Network collaborations

Last Updated: January 16, 2021

Content on this page maintained by the Office of Cancer Genomics

CSVXML